BioCryst Pharmaceuticals, Inc.
USD9.55
-0.39 (-3.92%)
CEO
Charles K. Gayer
IPO Date
1994-03-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$9.88
Prev. Close
$9.94
Day Low
$9.47
Day High
$10.04
52W Low
$6.00
52W High
$10.94
Market Cap
$2.00B
Volume
6.44M
| -17.5 |
| 31 Dec 2023 | FY | 98.6% | -68.4% | 49.7% | -43.8% | -1.81 | 3.31 | -5.1 |
| 31 Dec 2022 | FY | 97.6% | -91.2% | 83.9% | -44.9% | -2.52 | 4.90 | -8.6 |
| 31 Dec 2021 | FY | 95.4% | -117.1% | 172.0% | -31.3% | -5.55 | 5.46 | -13.5 |
| 31 Dec 2020 | FY | 90.6% | -1026.4% | 949.1% | -54.6% | -14.51 | 3.06 | -6.8 |
| 31 Dec 2019 | FY | 91.6% | -223.0% | -284.7% | -62.1% | 2.21 | 1.78 | -3.7 |
| 31 Dec 2018 | FY | 97.7% | -490.3% | 13.8% | -69.0% | -0.08 | 1.65 | -8.2 |
| 31 Dec 2017 | FY | 93.2% | -261.2% | 10.4% | -36.9% | -0.09 | 1.68 | -6.3 |
| 31 Dec 2016 | FY | 89.8% | -209.3% | 9.7% | -61.4% | -0.09 | 1.23 | -8.5 |
| 1.7 |
| 30 Sept 2025 | Q3 | 98.4% | 8.1% | -3.3% | 2.9% | -1.76 | 1.87 | 30.9 |
| 30 Jun 2025 | Q2 | 98.3% | 3.1% | -1.2% | 1.1% | -1.67 | 2.25 | 92.3 |
| 31 Mar 2025 | Q1 | 96.9% | 0.0% | -0.0% | 0.0% | -1.84 | 2.93 | 12239.2 |
| 31 Dec 2024 | Q4 | 95.3% | -20.4% | 5.6% | -5.5% | -1.77 | 2.63 | -14.6 |
| 30 Sept 2024 | Q3 | 97.2% | -12.0% | 3.0% | -2.9% | -1.80 | 2.78 | -28.0 |
| 30 Jun 2024 | Q2 | 98.4% | -11.6% | 2.7% | -2.7% | -1.73 | 2.82 | -27.2 |
| 31 Mar 2024 | Q1 | 98.6% | -38.1% | 7.4% | -7.6% | -1.74 | 3.73 | -7.4 |
| 31 Dec 2023 | Q4 | 98.2% | -66.1% | 13.6% | -11.9% | -1.81 | 3.31 | -4.9 |